Xeris Biopharma Holdings Inc
F:2B30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xeris Biopharma Holdings Inc
F:2B30
|
US |
|
Rolta India Ltd
BSE:500366
|
IN |
|
S
|
Spok Holdings Inc
F:FQV
|
US |
|
RENERGEN Ltd
OTC:RGNTF
|
ZA |
|
M
|
Minth Group Ltd
OTC:MNTHY
|
CN |
|
E
|
Electro Optic Systems Holdings Ltd
OTC:EOPSF
|
AU |
|
R
|
Reading International Inc
F:46B
|
US |
Shareholder Yield
Current shareholder yield for 
2B30 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2B30 Price
Xeris Biopharma Holdings Inc
| Average Annual Return | 15.85% |
| Standard Deviation of Annual Returns | 56.95% |
| Max Drawdown | -76% |
| Market Capitalization | 1B EUR |
| Shares Outstanding | 148 260 000 |
| Percentage of Shares Shorted |
N/A
|
